HADEA/2023/OP/0036 – Speed Up the Development of and Access to Innovative Medical Countermeasures | Tenderlake

HADEA/2023/OP/0036 – Speed Up the Development of and Access to Innovative Medical Countermeasures

Contract Value:
EUR 82M - 82M
Notice Type:
Contract award notice
Published Date:
06 June 2024
Closing Date:
Location(s):
BE100 Arr. de Bruxelles-Capitale/Arr. van Brussel-Hoofdstad (BE Belgium/BELGIQUE-BELGIË)
Description:
HADEA/2023/OP/0036 – Speed Up the Development of and Access to Innovative Medical Countermeasures

The subject of this call for tenders is to conclude service contracts for the purchasing of clinical and non-clinical services to speed up availability and access to innovative medical countermeasures (MCMs). The innovative MCMs include promising solutions that are indicated to diagnose/detect, prevent, protect from or treat conditions associated to serious cross border health threats.


Vaccines

Vaccines to combat antimicrobial resistance.


Broad Spectrum Antivirals – Respiratory

Broad spectrum antivirals targeting respiratory RNA viral families.


Broad Spectrum Antivirals – VHF

Broad spectrum antivirals – viral-haemorrhagic fevers.


Point of Care Metagenomic Sequencing

Point of care metagenomic sequencing for universal pathogen detection.

Awarded to:
Speed Up the Development of and Access to Innovative Medical Countermeasures – Vaccines to Combat Antimicrobial Resistance
Biofabri SLU, Pontevedra (ES)
Download full details as .pdf
The Buyer:
European Health and Digital Executive Agency (HaDEA), HADEA.A.2 – EU4Health/SMP Food
CPV Code(s):
73000000 - Research and development services and related consultancy services
73300000 - Design and execution of research and development